A detailed history of Ullmann Wealth Partners Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ullmann Wealth Partners Group, LLC holds 2,308 shares of ABT stock, worth $263,642. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,308
Previous 2,292 0.7%
Holding current value
$263,642
Previous $238,000 10.5%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.07 - $118.13 $1,601 - $1,890
16 Added 0.7%
2,308 $263,000
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $7,655 - $8,545
-76 Reduced 3.21%
2,292 $238,000
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $30,884 - $34,110
282 Added 13.52%
2,368 $269,000
Q4 2023

Jan 11, 2024

BUY
$90.19 - $110.4 $188,136 - $230,294
2,086 New
2,086 $229,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ullmann Wealth Partners Group, LLC Portfolio

Follow Ullmann Wealth Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ullmann Wealth Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ullmann Wealth Partners Group, LLC with notifications on news.